Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes

NCT01012037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

491

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: linagliptin low dose
DRUG: placebo
DRUG: linagliptin medium dose

Sponsor

Boehringer Ingelheim